• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker cuts the ribbon on European HQ

Stryker cuts the ribbon on European HQ

February 3, 2015 By Brad Perriello

Stryker cuts the ribbon on European HQ

Stryker (NYSE:SYK) last week officially cut the ribbon on its new European headquarters as it plans to increase its market share in Western Europe.

Kalamazoo, Mich.-based Stryker said the new facility occupies roughly 59,000 square feet in Amsterdam’s Southeast business district and features a new training center for healthcare providers.

During a conference call with investors discussing Stryker’s 4th-quarter results, executives said the company is pushing to revitalize its business in Western Europe. Each of Stryker’s 8 divisions will have a vice president & general manager in Europe, and each country there will have its own dedicated manager, CEO Kevin Lobo said during the call.

"[W]hen most companies are leaning away from Western Europe, we’re leaning in Western Europe, and it’s just because of our current market share position, which is far below what it is in many other countries in the world," Lobo said, noting that the new structure puts business from each division in Western Europe and the U.S. on the same profit & loss statement.

That gives "a lot more flexibility with your dollars, because you’ve bigger marketing budgets, you’ve bigger R&D budgets, you can move money around and so if you see an exciting opportunity in the U.K. or an exciting opportunity to invest in France, you can balance that against opportunities that exist in the United States and you can move resources more tangibly," he explained.

"Putting them all in Amsterdam, having a state of the art center in Amsterdam where we can actually train surgeons, these are investments that we just haven’t made in Western Europe historically and that’s 1 of the reasons why we’ve just never moved the dial [there]," Lobos said.

CFO Bill Jellison said Stryker transferred patents from other European nations to Holland and is also repatriating some $2 billion in cash generated in Europe.

"Most of those funds will be transferred to the US in the back half of 2015, Jellison said. "The transfer of the intellectual property provides us more flexibility in managing our operations in the future and aligns the ownership with where our primary European leadership team will be located."

Filed Under: News Well, Wall Street Beat Tagged With: Exports, Stryker

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy